START Madrid_Hospital Universitario HM Sanchinarro_CIOCC

Madrid 28050

4 studies enrolling now · 6 studies all time

What they study most

Germ Cell Tumor, HR+/HER2-negative Breast Cancer, Hepatocellular Carcinoma, KRAS Mutant Solid Tumors, Melanoma and Metastatic Colorectal Cancer, PD-L1-selected Solid Tumors, Solid Tumor, Squamous Cell Non-Small Cell Lung Cancer

Studies at this site

• A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors — Recruiting now
• TLN-372 in Advanced KRAS Mutant Solid Tumors — Recruiting now
• A Study of ZW251 in Participants With Advanced Solid Tumors — Recruiting now
• A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer — Recruiting now
• A Study to Evaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid Tumors — Completed
• A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma — Completed